Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Immunisation report 2018

Produced by the Public Health (Strategic Policy, Planning and Performance)
Authored by Statistics Jersey and published on 11 Jul 2019
Prepared internally, no external cost

Summary

‚ÄčThis report provides the annual update for immunisation rates for children and adults in Jersey

In 2018:

  • uptake for 1 year olds of the following were at or above the World Health Organisation (WHO) recommended national target of 95%
    • 6-in-1 vaccine (96%) which protects children against diphtheria, tetanus, pertussis, polio, Haemophilus influenza type B and hepatitis B (DTaP/IPV/Hib/HepB)
    • pneumococcal conjugate vaccine (PCV) (96%)
    • infant meningitis B (MenB) vaccine (95%)
  • uptake for 2 year olds of the following were at or above the World Health Organisation (WHO) recommended national target of 95%
    • 5-in-1 (DTaP/IPV/Hib) vaccine (98%)
    • first dose of the measles, mumps and rubella (MMR) (96%)
    • Haemophilus influenza type B/Meningitis C (Hib/MenC) vaccine (96%)
    • pneumococcal conjugate vaccine (PCV) (96%)
    • infant meningitis B (MenB) vaccine (96%); uptake of the MenB booster vaccine by 24 months is reported for the first time this year
  • for 5 year olds, uptake for the first dose of MMR (97%) and the Hib/MenC (95%) were at or above the 95% WHO recommendation; the 4-in-1 diphtheria, tetanus, acellular pertussis and inactivated polio vaccine (DTaP/IPV) uptake was 94%; the uptake for the full course of MMR (two doses) by 5 years old was 93%
  • 80% of eligible females (aged 12 to 13 years) received the full course of the human papillomavirus vaccine (HPV)
  • over half (55%) of the birth cohort who became eligible on their 70th birthday received the shingles vaccine, a significantly higher proportion compared to England, Scotland and Wales

Immunisation Report 2018


Back to top
rating button